Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Finnish (OMX) Healthcare Sector Analysis

UpdatedFeb 07, 2026
DataAggregated Company Financials
Companies14
  • 7D4.5%
  • 3M21.5%
  • 1Y23.1%
  • YTD11.9%

The Healthcare industry is up 2.4% in the last week, with Orion Oyj up 6.0%. This means that the industry has gained 21% over the past year. Looking forward, earnings are forecast to grow by 15% annually.

Sector Valuation and Performance

Has the Finnish Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 07 Feb 2026€13.3b€5.6b€367.7m22.4x36.3x2.4x
Mon, 05 Jan 2026€11.9b€5.6b€367.7m24.1x32.4x2.1x
Wed, 03 Dec 2025€11.6b€5.6b€367.7m24.4x31.4x2x
Fri, 31 Oct 2025€11.7b€5.6b€357.0m20.4x32.8x2.1x
Sun, 28 Sep 2025€12.1b€5.7b€419.6m19.7x28.8x2.1x
Tue, 26 Aug 2025€13.0b€5.7b€420.8m18.9x30.9x2.3x
Thu, 24 Jul 2025€13.2b€5.7b€423.6m18x31.1x2.3x
Sat, 21 Jun 2025€12.3b€5.5b€392.7m17.7x31.3x2.2x
Mon, 19 May 2025€11.6b€5.5b€391.1m19.5x29.6x2.1x
Wed, 16 Apr 2025€10.3b€5.4b€362.7m20.6x28.3x1.9x
Fri, 14 Mar 2025€10.9b€5.4b€364.7m20.1x29.9x2x
Sun, 09 Feb 2025€10.8b€5.2b€274.3m26.1x39.2x2.1x
Tue, 07 Jan 2025€9.4b€5.2b€274.3m20.8x34.1x1.8x
Thu, 05 Dec 2024€9.5b€5.2b€274.3m20.1x34.7x1.8x
Sat, 02 Nov 2024€9.5b€5.2b€274.1m22.9x34.8x1.8x
Mon, 30 Sep 2024€10.2b€5.0b€144.2m25.5x70.4x2x
Wed, 28 Aug 2024€9.9b€5.0b€141.5m24.7x70.1x2x
Fri, 26 Jul 2024€8.9b€5.0b€123.3m28.3x72x1.8x
Sun, 23 Jun 2024€8.5b€4.9b€115.7m29.2x73.5x1.7x
Tue, 21 May 2024€8.3b€4.9b€118.1m27.3x70.1x1.7x
Thu, 18 Apr 2024€7.3b€4.8b€108.0m31.5x67.4x1.5x
Sat, 16 Mar 2024€7.6b€4.8b€108.0m29.5x69.9x1.6x
Mon, 12 Feb 2024€8.6b€4.8b€135.4m32.6x63.6x1.8x
Wed, 10 Jan 2024€8.5b€4.8b€135.4m34x62.7x1.8x
Fri, 08 Dec 2023€7.4b€4.8b€135.4m29.4x54.9x1.6x
Sun, 05 Nov 2023€7.4b€4.8b€134.2m28.5x55.4x1.6x
Tue, 03 Oct 2023€7.6b€5.0b€270.4m27.2x28.2x1.5x
Thu, 31 Aug 2023€7.8b€5.0b€269.6m27.5x28.8x1.6x
Sat, 29 Jul 2023€7.7b€5.0b€277.7m30x27.6x1.5x
Mon, 26 Jun 2023€8.3b€5.0b€315.2m40.4x26.3x1.7x
Wed, 24 May 2023€8.8b€5.0b€314.4m40x28.1x1.8x
Fri, 21 Apr 2023€9.5b€5.0b€343.2m39.5x27.6x1.9x
Sun, 19 Mar 2023€9.0b€5.0b€335.5m35.3x27x1.8x
Tue, 14 Feb 2023€9.6b€5.4b€354.6m18.2x27x1.8x
Price to Earnings Ratio

27x


Total Market Cap: €9.6bTotal Earnings: €354.6mTotal Revenue: €5.4bTotal Market Cap vs Earnings and Revenue0%0%0%
Finnish Healthcare Sector Price to Earnings3Y Average 42.5x202420252026
Current Industry PE
  • Investors are pessimistic on the Finnish Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 35.7x which is lower than its 3-year average PE of 42.5x.
  • The 3-year average PS ratio of 1.9x is lower than the industry's current PS ratio of 2.3x.
Past Earnings Growth
  • Both revenue and earnings for companies in the Healthcare industry have remained mostly flat over the last three years.
  • This means that sales and the cost of doing business have remained relatively consistent over this period and subsequently, so have profits.

Industry Trends

Which industries have driven the changes within the Finnish Healthcare sector?

FI Market1.63%
Healthcare4.54%
Pharma5.99%
Healthcare Services1.08%
Biotech0%0
Medical Equipment-3.08%
Healthtech-3.43%
Life Sciences-3.96%
Industry PE
  • Investors are most optimistic about the Medical Equipment industry even though it's trading below its 3-year average PE ratio of 212x.
    • Analysts are expecting annual earnings growth of 30.6%, which is higher than its past year's earnings growth of 17.1% per year.
Forecasted Growth
  • Analysts are most optimistic on the Life Sciences industry, expecting annual earnings growth of 43% over the next 5 years.
  • In contrast, the Pharma industry is expected to see its earnings grow by 13% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
ORNBV Orion Oyj€73.856.0%
+€590.9m		40.9%PE33.2x
TTALO Terveystalo Oyj€10.342.0%
+€25.3m		-12.8%PE14.4x
PIHLIS Pihlajalinna Oyj€14.752.4%
+€7.9m		37.2%PE8.5x
BIOBV Biohit Oyj€3.340.9%
+€455.9k		2.5%PE22.4x

Latest News

REG1V
€19.28
Revenio Group Oyj
7D
-3.8%
1Y
-35.9%

REG1V: Product Operating Model Shift Will Drive Future Upside Potential

Analysts have nudged their fair value estimate for Revenio Group Oyj lower from €27.70 to €26.25, citing slightly adjusted assumptions for revenue growth, profit margin, discount rate and future P/E multiples. What's in the News Chief Financial Officer and Leadership Team member Robin Pulkkinen has resigned to take a role outside the company and will remain with Revenio Group Oyj through his notice period, leaving no later than June 2026 (Key Developments).
OPTOMED
€3.87
Optomed Oyj
7D
-1.8%
1Y
-8.7%
HEALTH
€1.60
Nightingale Health Oyj
7D
-11.4%
1Y
-42.5%

Preventative Care And Multiomics Adoption Will Support A Stronger Long Term Outlook

Catalysts About Nightingale Health Oyj Nightingale Health Oyj provides blood based molecular profiling that helps detect and track chronic disease risk for use in both health care and medical research. What are the underlying business or industry changes driving this perspective?
MODU
€1.16
Modulight Oyj
7D
-2.8%
1Y
12.6%

MODU: Future Outlook Will Favor Steady Earnings Quality At Current Pricing

Analysts have adjusted their price target for Modulight Oyj to €1.30 per share from €1.30 per share, citing updated assumptions on discount rate, revenue growth, profit margin and future P/E that still support that valuation level. Valuation Changes Fair Value: The indicative fair value remains unchanged at €1.30 per share.
TTALO
€10.34
Terveystalo Oyj
7D
2.0%
1Y
-12.8%

TTALO: Expanded Blood Analysis Partnership Will Support EPS Momentum Into 2025

Analysts have nudged their fair value estimate for Terveystalo Oyj higher from €11.30 to €11.64, citing updated assumptions around revenue growth, profit margins and future P/E expectations. What's in the News Terveystalo and Nightingale Health have signed a new agreement that deepens their partnership, first set up in 2021, focused on using blood analysis in healthcare services (Key Developments).
AIFORIA
€2.25
Aiforia Technologies Oyj
7D
-3.4%
1Y
-36.4%
BIOBV
€3.34
Biohit Oyj
7D
0.9%
1Y
2.5%
ORNBV
€73.85
Orion Oyj
7D
6.0%
1Y
40.9%
NXTMH
€12.70
Nexstim
7D
-2.3%
1Y
56.4%

Revenues Tell The Story For Nexstim Plc (HEL:NXTMH)

Jan 14
Revenues Tell The Story For Nexstim Plc (HEL:NXTMH)
HRTIS
€2.32
Herantis Pharma Oyj
7D
-0.9%
1Y
55.2%
NANOFH
€0.85
Nanoform Finland Oyj
7D
-4.0%
1Y
-28.1%
PIHLIS
€14.75
Pihlajalinna Oyj
7D
2.4%
1Y
37.2%